目次

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation & Scope
1.1.1 Source Type
1.1.2 Product Service Type
1.1.3 Disease Indication Type
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region Wise Market Calculation
1.6.1 Region Wise Market: Base Estimates
1.6.2 Global Market: Cagr Calculation
1.7 Model Details
1.7.1 Commodity Flow Analysis (Model 1)
1.7.2 Volume Price Analysis (Model 2)
1.7.2.1 Service Segment Analysis
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 List Of Secondary Sources
1.11 Objectives
1.11.1 Objective - 1:
1.11.2 Objective - 2:
1.11.3 Objective - 3:
1.11.4 Objective - 4:

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Biologics Contract Development Market: Variables, Trends, & Scope
3.1 Market Segmentation And Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Increasing Adoption Of Advanced Technologies
3.2.3 Increasing Mergers And Collaborations
3.2.4 Favorable Environment For Clinical Trials In Developing Countries
3.2.5 Increasing Outsourcing Of R&D Activities
3.2.6 Market Restraint Analysis
3.2.7 Intellectual Property Rights Issues
3.3 Penetration & Growth Prospect Mapping
3.4 Biologics Contract Development: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s Five Forces
3.4.2 Pestel Analysis
3.5 COVID-19 Impact On The Biologics Contract Development Market

Chapter 4 Biologics Contract Development Market: Source Type Segment Analysis
4.1 Biologics Contract Development Market: Market Share Analysis, 2021 & 2030
4.1.1 Microbial
4.1.1.1 Microbial Market, 2018 - 2030 (USD Million)
4.1.1.2 Mammalian
4.1.1.2.1 Mammalian Market, 2018 - 2030 (USD Million)
4.1.1.3 Others
4.1.1.3.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Biologics Contract Development Market: Product Service Segment Analysis
5.1 Biologics Contract Development Market: Market Share Analysis, 2021 & 2030
5.2 Cell Line Development
5.2.1 Cell Line Development Market, 2018 - 2030 (USD Million)
5.2.1.1 Microbial Cell Line Development
5.2.1.1.1 Microbial Cell Line Development Market, 2018 - 2030 (USD Million)
5.2.1.2 Mammalian Cell Line Development
5.2.1.2.1 Mammalian Cell Line Development Market, 2018 - 2030 (USD Million)
5.2.1.3 Others
5.2.1.3.1 Others Market, 2018 - 2030 (USD Million)
5.2.2 Process Development
5.2.2.1 Process Developmentmarket, 2018 - 2030 (USD Million)
5.2.2.2 Upstream Process Development
5.2.2.1.1 Upstream Process Development Market, 2018 - 2030 (USD Million)
5.2.2.1.1.1 Microbial
5.2.2.1.1.1.1 Microbial Market, 2018 - 2030 (USD Million)
5.2.2.1.2.1 Mammalian
5.2.2.1.2.1.1 Mammalian Market, 2018 - 2030 (USD Million)
5.2.2.1.3.1 Others
5.2.2.1.3.1.1 Others Market, 2018 - 2030 (USD Million)
5.2.3 Downstream Process Development
5.2.3.1 Downstram Process Development, 2018 - 2030 (USD Million)
5.2.3.1.1 Impurity, Isolation, & Identification
5.2.3.1.1.1 Impurity, Isolation, & Identification Market, 2018 - 2030 (USD Million)
5.2.3.1.2 Physicochemical Characterization
5.2.3.1.2.1 Physicochemical Characterization Market, 2018 - 2030 (USD Million)
5.2.3.1.3 Pharmaceutical Analysis
5.2.3.1.3.1 Pharmaceutical Analysis Market, 2018 - 2030 (USD Million)
5.2.3.1.4 Others
5.2.3.1.4.1 Others Market, 2018 - 2030 (USD Million)
5.3.1 Downstream Process, By Product
5.3.1.1 Mabs (Monoclonal Antibodies)
5.3.1.1.1 Mabs (Monoclonal Antibodies) Market, 2018 - 2030 (USD Million)
5.3.1.2. Recombinant Proteins
5.3.1.2.1 Recombinant Proteins Analysis Market, 2018 - 2030 (USD Million)
5.3.1.3 Others
5.3.1.3.1 Others Market, 2018 - 2030 (USD Million)
5.4 Other Product Service (Quality And Regulatory Services, Etc)
5.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Biologics Contract Development Market: Indication Segment Analysis
6.1 Biologics Contract Development Market: Market Share Analysis, 2021 & 2030
6.2 Oncology
6.2.1 Oncology Market, 2018 - 2030 (USD Million)
6.3 Immunological Disorders
6.3.1 Immunological Disorders Market, 2018 - 2030 (USD Million)
6.4 Cardiovascular Disorders
6.4.1 Cardiovascular Disorders Market, 2018 - 2030 (USD Million)
6.5 Hematological Disorders
6.5.1 Hematological Disorders Market, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 others Market, 2018 - 2030 (USD Million)

Chapter 7 Biologics Contract Development Market: Regional Analysis
7.1 Biologics Contract Development: Regional Market Share Analysis, 2021 & 2030
7.2 North America
7.2.1 North America Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.2 China
7.4.2.1 China Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.3 India
7.4.3.1 India Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.4 Japan
7.4.4.1 Japan Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colobia Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Biologics Contract Development Market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Biologics Contract Development Market, 2018 - 2030 (USD Million)

Chapter 8 Company Profiles
8.1 Compitative Landscape
8.2 Company Profile
8.2.1 Wuxi Biologics
8.2.1.1 Company Overview
8.2.1.2 Financial Performance
8.2.1.3 Service Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 Abzena Ltd
8.2.2.1 Company Overview
8.2.2.2 Service Benchmarking
8.2.2.3 Strategic Initiatives:
8.2.3 Fujifilm Diosynth Biotechnologies
8.2.3.1 Company Overview
8.2.3.2 Financial Performance
8.2.3.3 Service Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 Kbi Biopharma
8.2.4.1 Company Overview
8.2.4.2 Service Benchmarking
8.2.4.3 Strategic Initiatives
8.2.5 Agc Biologics
8.2.5.1 Company Overview
8.2.5.2 Financial Performance
8.2.5.3 Service Benchmarking
8.2.5.4 Strategic Initiatives:
8.2.6 Thermo Fischer Scientific Inc.
8.2.6.1 Company Overview
8.2.6.2 Financial Performance
8.2.6.3 Service Benchmarking
8.2.6.4 Strategic Initiatives:
8.2.7 Curia Global, Inc
8.2.7.1 Company Overview
8.2.7.2 Service Benchmarking
8.2.7.3 Strategic Initiatives:
8.2.8 Genscript
8.2.8.1 Company Overview
8.2.8.2 Financial Performance
8.2.8.3 Service Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 Bionova Scientific Inc.
8.2.9.1 Company Overview
8.2.9.2 Service Benchmarking
8.2.10 Bioxcellence (Boehringer Ingelheim Biopharmaceuticals Gmbh)
8.2.10.1 Company Overview
8.2.10.2 Financial Performance
8.2.10.3 Service Benchmarking
8.2.10.4 Strategic Initiatives:
8.2.11 Stc Biologics
8.2.11.1 Company Overview
8.2.11.2 Service Benchmarking

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume Price Analysis
Fig. 10 Biologics Contract Development market snapshot (2021)
Fig. 11 Biologics Contract Development market segmentation
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Biologics Contract Development market product type outlook: Segment dashboard
Fig. 18 Biologics Contract Development market: product movement analysis
Fig. 19 Microbial market, 2018 - 2030 (USD Million)
Fig. 20 Mammalian market, 2018 - 2030 (USD Million)
Fig. 21 Others market, 2018 - 2030 (USD Million)
Fig. 22 Biologics Contract Development market product service outlook: Segment dashboard
Fig. 23 Biologics Contract Development market: product movement analysis
Fig. 24 Cell Line Development market, 2018 - 2030 (USD Million)
Fig. 25 Microbial Cell Line Development market, 2018 - 2030 (USD Million)
Fig. 26 Mammalian Cell Line Development market, 2018 - 2030 (USD Million)
Fig. 27 Others market, 2018 - 2030 (USD Million)
Fig. 28 Process development market, 2018 - 2030 (USD Million)
Fig. 29 Upstream Process Development market, 2018 - 2030 (USD Million)
Fig. 30 Microbial market, 2018 - 2030 (USD Million)
Fig. 31 Mammalian market, 2018 - 2030 (USD Million)
Fig. 32 Others market, 2018 - 2030 (USD Million)
Fig. 33 Downstream Process Development market, 2018 - 2030 (USD Million)
Fig. 34 Impurity, isolation, & identification market, 2018 - 2030 (USD Million)
Fig. 35 Physicochemical characterization market, 2018 - 2030 (USD Million)
Fig. 36 Pharmaceutical analysis market, 2018 - 2030 (USD Million)
Fig. 37 Others market, 2018 - 2030 (USD Million)
Fig. 38 MABS (Monoclonal Antibodies) market, 2018 - 2030 (USD Million)
Fig. 39 Recombinant proteins market, 2018 - 2030 (USD Million)
Fig. 40 Others market, 2018 - 2030 (USD Million)
Fig. 41 Others market, 2018 - 2030 (USD Million)
Fig. 42 Biologics Contract Development market indication outlook: Segment dashboard
Fig. 43 Biologics Contract Development market: indication movement analysis
Fig. 44 Oncology market, 2018 - 2030 (USD Million)
Fig. 45 Immunological disorders market, 2018 - 2030 (USD Million)
Fig. 46 Cardiovascular disorders market, 2018 - 2030 (USD Million)
Fig. 47 Hematological disorders market, 2018 - 2030 (USD Million)
Fig. 48 Others market, 2018 - 2030 (USD Million)
Fig. 49 Regional market: Key takeaways
Fig. 50 Regional outlook, 2021 & 2030
Fig. 51 North America market, 2018 - 2030 (USD Million)
Fig. 52 U.S. market, 2018 - 2030 (USD Million)
Fig. 53 Canada market, 2018 - 2030 (USD Million)
Fig. 54 Europe market, 2018 - 2030 (USD Million)
Fig. 55 U.K. market, 2018 - 2030 (USD Million)
Fig. 56 Germany market, 2018 - 2030 (USD Million)
Fig. 57 France market, 2018 - 2030 (USD Million)
Fig. 58 Italy market, 2018 - 2030 (USD Million)
Fig. 59 Spain market, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 61 China market, 2018 - 2030 (USD Million)
Fig. 62 India market, 2018 - 2030 (USD Million)
Fig. 63 Japan market, 2018 - 2030 (USD Million)
Fig. 64 Australia market, 2018 - 2030 (USD Million)
Fig. 65 South Korea market, 2018 - 2030 (USD Million)
Fig. 66 Latin America market, 2018 - 2030 (USD Million)
Fig. 67 Brazil market, 2018 - 2030 (USD Million)
Fig. 68 Mexico market, 2018 - 2030 (USD Million)
Fig. 69 Argentina market, 2018 - 2030 (USD Million)
Fig. 70 Colombia market, 2018 - 2030 (USD Million)
Fig. 71 MEA market, 2018 - 2030 (USD Million)
Fig. 72 South Africa market, 2018 - 2030 (USD Million)
Fig. 73 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 74 UAE market, 2018 - 2030 (USD Million)